{"id":"W3022639174","doi":"10.1016/j.beha.2020.101170","title":"Establishing specific response criteria for MDS/MPN - Getting closer to reality?","year":2020,"lang":"en","type":"review","venue":"Best Practice & Research Clinical Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":0,"is_retracted":false,"has_abstract":false,"ca_institutions":"","funders":"Sierra Oncology; Astex Pharmaceuticals; Takeda Pharmaceuticals U.S.A.; TG Therapeutics; Karyopharm Therapeutics; Celgene; Bristol-Myers Squibb","keywords":"Medicine; Multiple myeloma; Disease; Oncology; Intensive care medicine; Internal medicine","routes":{"ca_aff":false,"ca_fund":true,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":true},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.02485169,0.00111123,0.007131594,0.002244964,0.0005263218,0.004143514,0.004681502,0.003977193,0.003979633],"category_scores_gemma":[0.03690022,0.0005784456,0.002570189,0.002285375,0.00231097,0.004541574,0.001714454,0.008031964,0.00170594],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.003443344,"about_ca_system_score_gemma":0.007824169,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.004085118,"about_ca_topic_score_gemma":0.006991142,"domain_scores_codex":[0.9908037,0.004437963,0.002014564,0.0009791043,0.001425852,0.0003388317],"domain_scores_gemma":[0.9699148,0.02130431,0.002868138,0.0005469761,0.004661619,0.0007041385],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0003035172,0.00006306911,0.0008814386,0.05904521,0.0008164209,0.00009207946,0.0001910268,0.0005092334,0.0003486811,0.01068588,0.05169926,0.8753642],"study_design_scores_gemma":[0.0005159421,0.0003942472,0.002772814,0.1744074,0.002576383,0.0008349167,0.0006441835,0.0006456599,0.0004623323,0.02045304,0.7961285,0.0001645292],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.00009396834,0.9883581,0.000467058,0.009439112,0.001052664,0.00001948004,0.0000385965,0.00001329559,0.000517765],"genre_scores_gemma":[0.004863257,0.9727026,0.004577587,0.01444016,0.002622653,0.0001180082,0.0002333481,0.00002155635,0.0004208304],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.02485169,"threshold_uncertainty_score":0.1314299,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.5253634270731835,"score_gpt":0.6398598484458549,"score_spread":0.1144964213726714,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}